Capital Cell is a venture capital fund that specializes in early-stage health tech and biotech investments, with check sizes ranging from $250k to $5M. The fund supports groundbreaking companies such as Ability Pharmaceuticals. Combining venture capital, business angels, and accredited investors, Capital Cell offers a unique equity crowdfunding platform for investing in non-listed companies. This approach enables global investors to support the future of medical science, providing detailed scientific and financial information on each project.
